QualityStocksNewsBreaks Archives - Page 418 of 1497

MondayNov 28, 2022 12:28 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K1 Technology Deployed for Transit System Client

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced that an existing California-based transit client signed a contract to upgrade 97 of its parking lot emergency call boxes with the Knightscope K1 Retrofit Kits. The announcement reads, “In 2022, this client averaged approximately 136,000 weekday passengers. Knightscope’s K1 emergency blue light communication devices serve to deter potential negative activities using cellular and satellite communications with solar power to passengers for additional safety in remote locations. The newer, more advanced wireless systems will save the client money on both infrastructure and hardware costs, while improving reliability on a…

MondayNov 28, 2022 11:27 am

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) to Participate in Upcoming One-on-One Investor Conference

FingerMotion (NASDAQ: FNGR) CEO Martin Shen is scheduled to participate in one-on-one meetings during the Benchmark Company’s 11th annual Discovery One-on-One Investor Conference. The one-day event is scheduled for Dec. 1, 2022, in New York City. During the conference, Shen will meet with potential investors as well as other interested parties. The conference offers emerging growth and dynamic publicly traded companies access to institutions and individuals in a unique one-on-one format. New York City-based Benchmark Company is an institutionally focused, research-driven, sales-trading and investment-banking company that focuses on fostering the long-term success of its corporate clients. The company accomplishes this…

MondayNov 28, 2022 11:09 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Q3 2022 Financial Results

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, released its financial and operating results for the third quarter and nine months ended Sept. 30, 2022. Among the highlights, the company reported 414% year-over-year and 510% year-over-year increases in revenue for the three-month period and nine-month period ended Sept. 30, 2022. In addition, Flora achieved a 703% year-over-year increase in gross profit for the three-month period ended Sept. 30, 2022. The company will discuss these results in its earnings call at 4:30 p.m. ET today, as detailed in the press release. “The third…

MondayNov 28, 2022 10:53 am

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Featured in Recent Power Play Interview

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, was spotlighted during a recent interview released by the Power Play by the Market Herald. During the interview, Eloro executive VP of exploration Bill Pearson chatted with host Sabrina Cuthbert about the company’s recent expansion of its holdings at its Brazil-based Iska Iska Silver-Tin Polymetallic Project. Pearson noted that the company will be acquiring the Mina Casiterita and Mina Hoyada properties, which are situated next to the Iska Iska Project. According to Pearson,…

WednesdayNov 23, 2022 3:05 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Seeking to Solve Unmet Need for GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) is an oncology drug development company specializing in developing anti-cancer drugs for the treatment of primary and metastatic brain and central nervous system cancer. “The first half of fiscal 2022 saw the company make a number of clinical and operational advancements in its pursuit of treatment for glioblastoma multiforme (‘GBM’), according to CNS Pharmaceuticals CEO John Climaco. The company’s focus and priorities, Climaco emphasized, are firmly anchored in the advancement of its clinical development for its drug candidate Berubicin with the aim of bringing meaningful treatment to GBM patients. And as he separately told attendees at…

WednesdayNov 23, 2022 2:08 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Bridging Gap Between Lidar Concept and Deployment with NVIDIA DRIVE Sim(TM)

Cepton (NASDAQ: CPTN) recently teamed up with NVIDIA to add its lidars into NVIDIA DRIVE Sim(TM) – an end-to-end simulation platform for large-scale, accurate multi-sensor simulation that supports autonomous driving development and validation from concept to deployment. “With this collaboration, Cepton seeks to accelerate the development of lidar solutions for assisted and autonomous driving for global consumers. NVIDIA DRIVE Sim simulations enable automakers and developers to work with Cepton’s lidar models in a virtual environment to identify suitable Cepton lidar sensors for specific application needs and integrate them with other sensor technologies, such as camera and radar. They can prototype…

WednesdayNov 23, 2022 12:05 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Exec Featured in New Article

Correlate Infrastructure Partners (OTCQB: CIPI) director of corporate business development, Jason Loyet, is featured in a recent article. The article, titled “Get to Know Jason Loyet,” is a Q&A-format piece that provides an overview of Loyet’s background, role at the company and goals. The article also discussed Loyet’s team as well as what he does outside of work. CIPI is a technology-enabled energy optimization and clean-energy solutions provider for North America, and Loyet is focused on project development, assisting the senior management team with aggressive acquisition strategies and evolving the company’s growing ecosystem of partners. In the article, Loyet states…

WednesdayNov 23, 2022 11:43 am

QualityStocksNewsBreaks – Coyuchi Inc. Leveraging Simple yet Effective Approach to Drive Visible Growth

Coyuchi, an organic luxury home goods brand for sustainable living, was recently featured in a published review by KingsCrowd, an analyst news publication for startup investing. “In the KingsCrowd report, titled ‘Coyuchi Is Sewing Sustainability Into Home Goods,’ author Francis Vu points out that consumers across the board are trying to shop and live more sustainably – and since inception, Coyuchi has made sustainability a core value…. Coyuchi consumers can return used goods through the company’s ‘2nd Home Take Back’ program, which recycles and renews used Coyuchi linens and cleans, mends and resells refurbished products. These products are sold for…

WednesdayNov 23, 2022 11:10 am

QualityStocksNewsBreaks – CubCrafters Inc. Featured in Aero News Network and GlobalAir.com Articles

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, was featured in recent articles published by Aero News Network and GlobalAir.com. The publications discuss qualification of CubCrafters by the Securities Exchange Commission (“SEC”) for a $50 million public stock offering under the Regulation A+ exemption. Advised by Manhattan Street Capital, this is the first outside investment for the popular backcountry aircraft manufacturer. “The already significant response from investors and their large and loyal customer base is a strong testimonial to CubCrafters’ role as an industry leader and to the quality of its product line,”…

WednesdayNov 23, 2022 10:59 am

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Reports on Concussion Drug Progress, Provides Corporate Update

Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a medical technology company focused on developing unique, life-saving medical products, has released an update on its concussion drug-development program. According to the release, in March 2022 the company acquired key intellectual property (“IP”) to a concussion drug, along with all rights to that drug. During the past few months, the company has completed strategic steps to develop the drug, including appointing two new members of the management team with expertise in progressing drugs through the clinical phase and to the market; completing an FDA-required IND in order to move forward…

Site Search

Company Search

Category: QualityStocksNewsBreaks